Related Experiment Video
Updated: Aug 6, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
The risk of congestive heart failure: sobering lessons from the Framingham Heart Study
1Cardiology Division, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. dlloydjones@partners.org
Insights
The Framingham Heart Study reveals a 20% lifetime risk for congestive heart failure (CHF). Hypertension is a key modifiable risk factor, significantly increasing CHF development and impacting prognosis.
Area of Science:
- Cardiology
- Epidemiology
- Public Health
Background:
- Congestive heart failure (CHF) poses a significant public health challenge.
- Understanding the epidemiology of CHF is crucial for effective prevention and management.
- The Framingham Heart Study offers a unique, long-term perspective on cardiovascular disease in a community-based population.
Purpose of the Study:
- To review recent contributions of the Framingham Heart Study to the epidemiology of congestive heart failure (CHF).
- To elucidate risk factors, prognosis, and incidence of CHF in a general population.
- To highlight advancements in predicting and understanding CHF development.
Main Methods:
- Longitudinal, community-based cohort study.
- Uniform diagnostic criteria for congestive heart failure (CHF).
- Analysis of incidence, risk factors, and survival rates over extended follow-up periods.
Main Results:
- Estimated lifetime risk of congestive heart failure (CHF) is 20% for both men and women.
- Hypertension identified as the primary modifiable risk factor, accounting for 59% of CHF in women and 39% in men.
- A clinical prediction rule for CHF development has been established; prognosis remains poor with median survival of 1.7 years (men) and 3.2 years (women).
Conclusions:
- The Framingham Heart Study provides critical epidemiological data on congestive heart failure (CHF).
- Aggressive management of hypertension is paramount for reducing CHF burden.
- Further research and clinical tools are needed to improve CHF outcomes.
Abstract:
This review highlights recent contributions of the Framingham Heart Study to our understanding of the epidemiology of congestive heart failure (CHF). Given its uniform criteria for the diagnosis of CHF and its long duration of follow-up, the Framingham study has had a unique perspective on the short- and long-term risk of developing CHF, its predisposing risk factors, and its prognosis in a general, community-based population. Some recent studies from Framingham have provided important insights on CHF: the lifetime risk is estimated to be 20% for men and women; hypertension is the most important modifiable risk factor, with a population-attributable risk of CHF of 59% for women and 39% for men; a clinical prediction rule for development of CHF has recently been published; and the prognosis after development of CHF is grim, with a median survival of 1.7 years in men and 3.2 years in women.
More Related Videos
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation